Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin & lt;1 ng/mL before the first disease assessment?

ConclusionTSH suppression before the first response to treatment assessment does not seem to influence the rate of disease recurrence after initial therapy in intermediate- and high-risk PTC patients with pre-ablation s-Tg < 1 ng/mL.

http://link.springer.com/10.1007/s12020-019-01914-z

Source: Endocrine - March 27, 2019 Category: Endocrinology Source Type: research